Investigating Splicing Efficiency in HRAS to Control Costello Syndrome Phenotype and Frequency in Cancer

Article   Jul 06, 2016

 
Investigating Splicing Efficiency in HRAS to Control Costello Syndrome Phenotype and Frequency in Cancer
 
 
 

RELATED ARTICLES

Navigating Drug Discovery with High-Throughput Screening

Article

Once the preserve of big pharma, high-throughput screening and the data it has produced is now widely available. Together with advances in artificial intelligence, it is providing broad opportunities in drug discovery.

READ MORE

Treating Cancer: Tackling Drug Resistance

Article

One of the biggest barriers to treating cancer is drug resistance, a phenomenon that remains only partially understood. While drug resistance has been a problem in cancer for years, new treatments are coming to light that could help overcome it...

READ MORE

The Changing Role of Pathologists in the Age of Precision Medicine

Article

We spoke to Dr Philippe Taniere, Consultant Histopathologist/Molecular Pathology, and Dr Matthew Evans, Specialist Registrar at University Hospitals Birmingham, to learn how the role of pathologists is changing, what this means for oncologists and cancer patients, and some of the challenges these changes may present.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Cancer Research Diagnostics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE